Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Gribbin

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Statistics in Medicine|December 14, 2011
Global hypothesis testing for high-dimensional repeated measures outcomesYueh-Yun Chi, Matthew Gribbin, Yvonne Lamers, et al.
Journal of General Internal Medicine|July 30, 2005
How well do clinic-based blood pressure measurements agree with the mercury standard?Jennifer W Kim, Hayden B Bosworth, Corrine I Voils, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2018
Phase I Study of MEDI3617, a Selective Angiopoietin-2 Inhibitor Alone and Combined with Carboplatin/Paclitaxel, Paclitaxel, or Bevacizumab for Advanced Solid TumorsDavid M Hyman, Naiyer Rizvi, Ronald Natale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid TumorsBonnie S Glisson, Rom S Leidner, Robert L Ferris, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Statistics in Medicine|December 14, 2011
Global hypothesis testing for high-dimensional repeated measures outcomesYueh-Yun Chi, Matthew Gribbin, Yvonne Lamers, et al.
Journal of General Internal Medicine|July 30, 2005
How well do clinic-based blood pressure measurements agree with the mercury standard?Jennifer W Kim, Hayden B Bosworth, Corrine I Voils, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2018
Phase I Study of MEDI3617, a Selective Angiopoietin-2 Inhibitor Alone and Combined with Carboplatin/Paclitaxel, Paclitaxel, or Bevacizumab for Advanced Solid TumorsDavid M Hyman, Naiyer Rizvi, Ronald Natale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid TumorsBonnie S Glisson, Rom S Leidner, Robert L Ferris, et al.
Pageof 1